NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SILO
Silo Pharma, Inc.
There isn't enough reported data to score SILO yet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SILO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
SILO's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
SILO PE Valuation
SILO has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
SILO Forward outlook
There aren't enough analyst estimates for SILO to show an outlook.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the stronger earnings trend. Trailing diluted EPS is up 4.9% for NVO versus SILO down 177%.
SILO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$13.80 | +$4.07 |
| Q2 2025 | -$15.30 | +$2.42 |
| Q1 2025 | -$17.10 | +$0.77 |
| Q4 2024 | -$17.85 | +$0.17 |
| Q3 2024 | -$17.87 | +$12.45 |
| Q2 2024 | -$17.72 | +$16.80 |
| Q1 2024 | -$17.87 | +$19.35 |
| Q4 2023 | -$18.02 | +$14.85 |
SILO is still losing money, but far less than before: $13.80 per share over the past year, against $52.50 at its worst in mid-2020.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over SILO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over SILO on profitability, with a higher operating margin.
SILO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $18K | 0% |
| Q4 2025 | $18K | 0% |
| Q3 2025 | $18K | 0% |
| Q2 2025 | $18K | 0% |
| Q1 2025 | $18K | 0% |
| Q4 2024 | $18K | 0% |
| Q3 2024 | $18K | 0% |
| Q2 2024 | $18K | 0% |
SILO's revenue has slid since its 2021 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -8846% | -2777 points |
| Q4 2025 | -4363% | +5696 points |
| Q3 2025 | -6388% | -785 points |
| Q2 2025 | -6927% | -1364 points |
| Q1 2025 | -6070% | -1191 points |
| Q4 2024 | -10060% | -3604 points |
| Q3 2024 | -5604% | -1313 points |
| Q2 2024 | -5563% | +623 points |
SILO's operating margin was −8846% last quarter, down 2777 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over SILO on cash generation, producing positive trailing cash flow while its opponent burns cash.
SILO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$781.9K | +$503.4K |
| Q1 2026 | -$822.6K | +$817.7K |
| Q4 2025 | -$780.3K | +$137.2K |
| Q3 2025 | -$955.5K | +$391K |
| Q2 2025 | -$1.3M | -$553.5K |
| Q1 2025 | -$1.6M | -$802.1K |
| Q4 2024 | -$917.4K | -$7.4K |
| Q3 2024 | -$1.3M | -$274.7K |
SILO has burned cash in almost every quarter: −$3M over the past year, against −$5M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over SILO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
SILO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +20% | +185K shares |
| 1 year | +267% | +800K shares |
| 3 years | +422% | +888K shares |
| 5 years | +876% | +986K shares |
| Available history | +3411% | +1.1M shares |
SILO has 1M diluted shares, up 267% from a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
SILO Net Leverage
SILO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
SILO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.7 | Neutral |
| Stochastic | 12.9 | Oversold |
SILO's weekly RSI is 35 (neutral) and its Stochastic is 13 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
SILO PE vs Healthcare Sector
| Metric | SILO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SILO has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
SILO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.44 | 33% above |
| 20 week MA | $2.77 | 31% below |
| 50 week MA | $4.58 | 58% below |
| 100 week MA | $8.91 | 79% below |
| 200 week MA | $17.4 | 89% below |
SILO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 89% below its 200-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over SILO on returns for 2026, with the stronger performance.
SILO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $262.5 | $101.3 | -61% |
| 2022 | $101.3 | $45.0 | -56% |
| 2023 | $45.0 | $21.6 | -52% |
| 2024 | $21.6 | $14.1 | -35% |
| 2025 | $14.1 | $5.47 | -61% |
| 2026 YTD | $5.47 | $1.91 | -65% |
SILO has finished every year since 2021 lower, and it's down 65% so far in 2026.